Stockreport

Intellipharmaceutics Announces FDA Advisory Committee Meeting for Rexista™ (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to ...

INTELLIPHARMACEUTICS  (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com
PDF TORONTO, June 30, 2017 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical [Read more]